K-numberK243831
Device nameRayvolve LN
ApplicantAZmed
Product codeMYN
Device classClass II
Decision dateMar 26, 2025
DecisionSubstantially Equivalent
Regulation892.2070
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Rayvolve LN is a computer-aided detection software that assists radiologists in identifying and marking suspected pulmonary nodules (6-30mm) on frontal chest X-rays (AP/PA views) in patients 18 years or older. It processes DICOM images and provides adjunctive information as a second reader tool, not as a substitute for the original radiograph.

Technological characteristics

Rayvolve LN uses supervised deep learning (versus the predicate's machine learning), detects nodules from 6-30mm (predicate: 10-30mm), supports both AP and PA views (predicate: PA only), and works with any DICOM Node server rather than being tied to a specific imaging system. Both use DICOM input format and output regions of interest (ROI) marked on duplicated images.

Test standards cited

Not stated in this summary.

Substantial equivalence argument

Both devices share identical intended use (second-reader CAD for pulmonary nodule detection on chest radiographs), regulatory classification (Class II, MYN code), and clinical objective. The predicate's size range (10-30mm) is subsumed within Rayvolve's range (6-30mm); clinical testing demonstrated equivalent accuracy for smaller nodules. Support for AP views (clinically relevant for bedside radiography) was validated to achieve equivalent accuracy to PA views. Performance testing (sensitivity 0.8847, specificity 0.8294, AUC 0.8408 on 2181 radiographs; reader study showing AUC improvement from 0.8071 to 0.8583 when aided) demonstrates comparable or superior performance with no new safety or effectiveness concerns.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →